American Journal of Cardiovascular Drugs
ISSN:
1175-3277
Country:
Switzerland
ES-FAC
ES-FAC C
Eurascience Journal Classification System
📄 Articles published in this journal
- Comment on “Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials” 2026
- Additive Effects of Angiotensin Receptor–Neprilysin Inhibitors and Sodium–Glucose Cotransporter 2 Inhibitors on Neurohormonal Inhibition Therapy in Severe HFrEF: A Systematic Review and Network Meta-analysis 2026
- Hypertension in Diabetes: Numbers or Outcomes? 2026
- Impact of Prestroke Antiplatelet Therapy on the Efficacy of Intravenous Tirofiban at Preventing Early Neurological Deterioration: A Prespecified Subgroup Analysis of the TREND Trial 2026
- Authors’ Reply to Khan et al. “Evaluating the Effectiveness and Safety of Evinacumab in Treating Hypercholesterolemia and Hypertriglyceridemia: A Systematic Review and Meta-analysis of Randomized Controlled Trials” 2026
- Emerging Role of Weight-Loss Medications in the Management of Heart Failure: Current Evidence and Future Perspectives 2025
- Contemporary Antianginal Therapy 2025
- Authors’ Reply to Umińska and Fabiszak: ‘Morphine and P2Y12 inhibitors in ST-Elevation Myocardial Infarction: An Updated Meta-Analysis’ 2025
- A Drug–Drug Interaction Study Evaluating the Pharmacokinetic Consequences of Obicetrapib Therapy on Atorvastatin or Rosuvastatin Levels in Healthy Volunteers 2025
- Bempedoic Acid: A Review in Cardiovascular Risk Reduction in Statin-Intolerant Patients 2025